Objective Response in Recurrent Glioblastoma from Adjuvant NovoTTF-100A and TCCC after Temozolomide and Bevacizumab Failure: T2109.


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles